cystoid macular edema in diabetic patients after treatment for cmv retinitis (cmvr) with ganciclovir implants.

NLM AIDSLINE Cystoid macular edema in diabetic patients after treatment for CMV retinitis (CMVR) with ganciclovir implants. Lieberman R; Orellana J; Roseman JB; Mount Sinai School of Medicine, New
December 30, 1998

Int Conf AIDS. 1998;12:567 (abstract no. 32236). Unique Identifier : OBJECTIVE: To determine if non-insulin dependent diabetes mellitus (NIDDM) or insulin dependent diabetes mellitus (IDDM) impacts upon the development of cystoid macular edema (CME) after ganciclovir implant (Vitrasert) surgery. DESIGN: Retrospective study. METHODS: The records of 54 patients (76 eyes) who had previously received ganciclovir implants were analyzed (98 procedures performed). Patients were divided into three groups: those having insulin dependent diabetes mellitus (IDDM), those having non-insulin dependent diabetes mellitus (NIDDM), and those not having diabetes (groups 1, 2, and 3). All patients received identical postoperative medications and had the implants placed using the same, standard surgical technique. All patients had frequent, full ophthalmic examinations, including indirect ophthalmoscopy and contact lens examination of the macula. Fluorescein angiography was performed to determine the status of the macula, if deemed necessary on examination. RESULTS: Of 54 patients who received ganciclovir implants between 12/94 and 12/97 (76 eyes), 14 patients (22 eyes) were found to be diabetic. Six (10 eyes) had IDDM, and 8 (12 eyes) had NIDDM. Four patients (66%) or 28% of procedures in group 1 developed CME, while 4 (50%) or 30.8% of procedures in group 2 developed CME. Of the 40 non-diabetic patients, 4 (10%) developed CME, or 5.6% of procedures. There is a statistically significant difference between the groups. CONCLUSION: IDDM may increase the patient's chance of developing CME after implant surgery. Careful postoperative assessment of the macula is warranted, especially in diabetic patients. MEETING ABSTRACTS Cytomegalovirus Infections/DRUG THERAPY Diabetes Mellitus, Insulin-Dependent Diabetes Mellitus, Non-Insulin-Dependent Diabetic Retinopathy/ETIOLOGY Drug Implants Ganciclovir/ADMINISTRATION & DOSAGE/THERAPEUTIC USE Human Macular Edema, Cystoid/ETIOLOGY Postoperative Complications Retinitis/VIROLOGY Retrospective Studies

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Initiation rules help to keep young men safe and healthy Navajo Confront an Increase in New H.I.V. Infections TB, HIV and malaria vaccine research gets major boost Measuring hidden HIV Investigators at National Autonomous University Detail Findings in AIDS Education and Prevention Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases Adopted Russian orphan triumphs over challenges 26th Annual Minnesota AIDS Walk - Sunday, May 19, Minnehaha Park Viet Nam: South-South learning helps prepare for sustainable provision of AIDS treatment Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 Legal help for AIDS patients China and Africa Discuss Health Treatment Problems Simpler ARV treatment begins in Eastern Cape UNITED STATES: Pretreatment Anemia Raises Mortality Risk Among HCV/HIV Coinfected Patients New Research Uncovers Willful Misrepresentation of Medical Data in Creation of AIDS "Patient Zero" Myth GEORGIA: Director of AIDS Athens 'Inspired' from Helping Her Patients Okla. Health Dept. accounts for juvenile patients Sustiva (efavirenz) pediatric patients labeling update
Information in this article was accurate in December 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.